HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Marketing In Brief

This article was originally published in The Rose Sheet

Executive Summary

Stiefel Laboratories: New GlaxoSmithKline unit says its Impruv Natural Repair line, available at Walgreens locations nationwide and online at Drugstore.com and Amazon.com, features "a patented and proven European technology that replenishes the lipids your skin produces naturally with six botanicals (coconut oil, palm oil, olive oil, wheat germ, soy, shea butter) to help repair extra-dry skin on the hands, body and feet." National television, Internet and print advertising are in the works; additionally company is launching an extensive public relations campaign with dermatologist spokespersons and will target more docs with a promotion and sampling effort driven by 200 sales reps, it says. Impruv cream (5.5 oz.) and Impruv lotion (6.67 oz.) retail for $12.99 each. Stiefel also plans to introduce a "revolutionary new acne product," PanOxyl Acne Treatment Foam. The product uses the firm's patented ERSAFOAM-AF technology to deliver 10 percent benzoyl peroxide to the skin. "The first foam leave-on treatment in the acne category is specially formulated to minimize irritation while delivering the active ingredient directly to the source of the problem," the company says. Advertising for the product will begin in August. PanOxyl is priced at $11.99 for 2.64-oz

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016316

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel